INFLUENCE OF MUMIYO ON HEMOSTASIS DURING INDOMETHACIN-INDUCED PROSTAGLANDIN SUPPRESSION
DOI:
https://doi.org/10.55640/Keywords:
Mumiyo, Indomethacin, Prostaglandins, Blood coagulation, Thromboelastography, Hemostasis.Abstract
This study aimed to evaluate the effect of mumiyo on blood coagulation under conditions of inhibited prostaglandin synthesis using indomethacin. Experiments were conducted on dogs, and blood coagulation was assessed by thromboelastography. Baseline coagulation parameters were recorded prior to drug administration. Indomethacin was administered intravenously at a dose of 5 mg/kg to inhibit prostaglandin synthesis. After the development of its effect, mumiyo extract was injected intravenously at a dose of 50 mg/kg. Thromboelastographic parameters were measured at various time intervals following each intervention. Indomethacin produced time-dependent alterations in thromboelastographic indices, characterized by transient procoagulant changes. Some parameters showed partial recovery within 30–60 minutes after administration. Subsequent administration of mumiyo modified these effects, resulting in a tendency toward normalization of coagulation parameters and indicating a mild hypocoagulant influence. Inhibition of prostaglandin synthesis by indomethacin leads to transient changes in blood coagulation. Mumiyo administration under these conditions exerts a moderate regulatory effect on hemostasis, suggesting that its anticoagulant action is at least partially independent of prostaglandin-mediated mechanisms.
Downloads
References
1. World Health Organization (WHO), 2000. General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization, Geneva.
2. Shahriari M, Zare F, Nimrouzi M. The Curative Role of Bitumen in Traditional
Persian Medicine. Acta Med Hist Adriat. 2018;16(2):283-92
3. Ghosal S. 2006. Shilajit in Perspective. Narosa Publishing House, New Delhi India.
4. Olivieri MF, Marzari F, Kesel AJ, Bonalume L, Saettini F. Pharmacology and psychiatry at the origins of Greek medicine: The myth of Melampus and the madness of the Proetides. J Hist Neurosci. 2017;26(2):193-215.
5. Wilson E, Rajamanickam GV, Dubey GP,et al.2011. Review on shilajit used in traditional Indian medicine.J Ethnopharmacol 136:1–9
6. Schepetkin I, Khebnikov A, Kwon BS. 2002. Medical drugs from humus matter: focus on mumie.Drug Devel Res57: 140–159
7. Shirbeigi L ZA, Naghizadeh A, Alizadeh Vaghasloo M. The Concept of Temperaments in Traditional Persian Medicine. Trad Integr Med. 2017;2(3):143-56.
8. Frolova N, Kiseleva L, Tatiana. Chemical composition of mumijo and methods for determining its authenticity and quality (a review). Pharma Chem J. 1996;30(8):543-7.
9. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res. 2007;21(5):401-5.
10. Verma A, Kumar N, Gupta L, Chaudhary S. Shilajitin Cancer Treatment: Probable Mode of Action. Int J Pharmaceutic Bio Arch. 2016;7(1):12-6.
11. Stohs SJ, Singh K, Das A, Roy S, Sen CK. 12-Energy and Health Benefits of Shilajit. In: Bagchi D, editor. Sustained Energy for Enhanced Human Functions and Activity. Academic Press; 2017. p. 187-204
12. Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of Shilajit by its isolated active constituents. Phytother Res. 1991;5(5):211-6
13. Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. Indian J Pharmacol. 2004;36(6):373-6.
14. Загрутдинов, Ф. Ф., Мамадалиев, Ш. И., & Болтабоева, Д. Ф. (2024). Влияние Среднеазиатских Видов Мумиё на диурез и натрий урез у Крыс. Open Herald: Periodical of Methodical Research, 2(5), 12-14.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India